Estrella Immunopharma, Inc.
Estrella Immunopharma, Inc.
- Market cap
- $19.41M
Your view on ESLAW
Overview
What the company does, where it operates, and who runs it.
About Estrella Immunopharma, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Cheng Liu
- Headquarters
- 5858 Horton Street, EmeryVille, CA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Cheng Liu
- Headquarters
- 5858 Horton Street, EmeryVille, CA, US
Estrella Immunopharma, Inc. is an early-stage biopharmaceutical firm based in Emeryville, California, dedicated to advancing T-cell immunotherapies for various hematological malignancies and solid tumors within the United States.
Its lead investigational treatments include EB103, currently undergoing preclinical assessment for diffuse large B-cell lymphoma, and EB104, which targets both diffuse large B-cell lymphoma and acute lymphocytic leukemia.
The company also collaborates with Imugene Limited to develop solid tumor therapies, integrating Imugene's candidate CF33-CD19t with Estrella's EB103.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Estrella Immunopharma, Inc.. Starting points for Estrella Immunopharma, Inc.: EPS -$0.29, beta -0.09 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Estrella Immunopharma, Inc.. Trailing twelve-month EPS for Estrella Immunopharma, Inc. stands at -$0.29. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Estrella Immunopharma, Inc.. Estrella Immunopharma, Inc. has reported as a listed company since 2023. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| AURXNuo Therapeutics, Inc. | Healthcare | OTC | $72.4M | ||
| AUTLAutolus Therapeutics plc | Healthcare | NASDAQ | $241.7M | ||
| AVBPArriVent BioPharma, Inc. Common Stock | Healthcare | NASDAQ | $544.1M | ||
| AVCTFAvacta Group Plc | Healthcare | OTC | $372.9M | ||
| AVE.AXAvecho Biotechnology Limited | Healthcare | ASX | — | ||
| AVEFFAvecho Biotechnology Limited | Healthcare | OTC | $13.4M | ||
| AVIRAtea Pharmaceuticals, Inc. | Healthcare | NASDAQ | $318.0M | ||
| AVLNAvalyn Pharma Inc. Common Stock | Healthcare | NASDAQ | $1.3B | ||
| AVTXAvalo Therapeutics, Inc. | Healthcare | NASDAQ | $390.9M | ||
| AVXLAnavex Life Sciences Corp. | Healthcare | NASDAQ | $54.8M | ||
| AXIMAXIM Biotechnologies, Inc. | Healthcare | OTC | $3.7M | ||
| AXSMAxsome Therapeutics, Inc. | Healthcare | NASDAQ | $6.8B | ||
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Estrella Immunopharma, Inc., and how their positions are changing. At a $19.4M market value, institutional positions materially move Estrella Immunopharma, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Estrella Immunopharma, Inc. executives and directors. Shares of Estrella Immunopharma, Inc. have traded between $0.06 and $0.11 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Estrella Immunopharma, Inc.. Coverage tracks Estrella Immunopharma, Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Estrella Immunopharma, Inc.